probably on 'hold' because BP wants to get a jump start with their inferior drugs, influence the EFFDA to give approval and then the EFFDA can use it to claim that since there already is an 'effective' drug to treat LH, CYDY/LL will have to prove again that LL is safe and that it is clinically statistically significant to the point that it is 'significantly' better than the SOC.

Same old story.